Versican has been observed in many malignancies, including melanoma, epithelial ovarian cancer, breast cancer and non-small cell lung cancer,7, 9, 10, 11, 15 implying its importance in tumor maintenance. Here, VCAN is linked to non-small cell lung carcinoma.